Evaluation of the role of peroxisome proliferator-activated receptor α (PPARα in mouse liver tumor induction by trichloroethylene and metabolites

Critical Reviews in Toxicology

Volumn 38, Issue 10, 2008, Pages 857-875

  Corton, J Christopher ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Chloral hydrate; Dichloroacetic acid; Liver tumors; Perchloroethylene; PPAR ; Trichloroacetic acid; Trichloroethylene

Indexed keywords

DICHLOROACETIC ACID; DRUG METABOLITE; MOLECULAR MARKER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRICHLOROACETIC ACID; TRICHLOROETHYLENE;

CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; HUMAN; HYPOTHESIS; LIVER CARCINOGENESIS; LIVER TUMOR; NONHUMAN; REVIEW; RODENT; UNCERTAINTY;

ANIMALS; DICHLOROACETATE; ENVIRONMENTAL POLLUTANTS; LIVER NEOPLASMS; MICE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; TETRACHLOROETHYLENE; TRICHLOROACETIC ACID; TRICHLOROETHYLENE;

MUS; RODENTIA;

EID: 56449124307     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.1080/10408440802209796     Document Type: Review

References (149)

1. Alexander, D.D., Kelsh, M.A., Mink, P.J., Mandel, J.H., Basu, R., and Weingart, M. (2007). A meta-analysis of occupational trichloroethylene exposure and liver cancer. Int. Arch. Occup. Environ. Health 81:127-143.
2. Alexander, D.D., Mink, P.J., Mandel, J.H., and Kelsh, M.A. (2006). A meta-analysis of occupational trichloroethylene exposure and multiple myeloma or leukaemia. Occup. Med. (Lond.) 56:485-493.
3. Anderson, S.P., Dunn, C., Laughter, A., Yoon L., Swanson, C., Stulnig, T.M., Steffensen, K.R., Chandraratna, R.A., Gustafsson, J.A., and Corton, J.C. (2004a). Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver. Mol. Pharmacol. 66:1440-1452.
4. Anderson, S.P., Howroyd, P., Liu, J., Qian,. X., Bahnemann, R., Swanson, C., Kwak, M.K., Kensler, T.W., and Corton, J.C. (2004b). The transcriptional response to a peroxisome proliferator-activated receptor alpha agonist includes increased expression of proteome maintenance genes. J. Biol. Chem. 279:52390-52398.
5. Anderson, S.P., Yoon, L., Richard, E.B., Dunn, C.S., Cattley, R.C., and Corton, J.C. (2002). Delayed liver regeneration in peroxisome proliferator-activated receptor-alpha-null mice. Hepatology. 36:544-554.
6. Anna, C.H., Maronpot, R.R., Pereira, M.A., Foley, J.F., Malarkey, D.E., and Anderson, M.W. (1994). ras proto-oncogene activation in dichloroacetic acid-trichloroethylene- and tetrachloroethylene-induced liver tumors in B6C3F1 mice. Carcinogenesis 15:2255-2561.
7. Ashby, J., Brady, A., Elcombe, S.R., Elliott, B.M., Ishmael, J., Odum, J., Tugwood, J.D., Kettle, S., and Purchase, I.F. (1994). Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol. 13:S1-S117.
8. Austin, E.W., Okita, J.R., Okita, R. T., Larson, J.L., and Bull, R.J. (1995). Modification of lipoperoxidative effects of dichloroacetate and trichloroacetate is associated with peroxisome proliferation. Toxicology 97:59-69.
9. Barber, E.D., Astill, B.D., Moran, E.J., Schneider, B.F., Gray, T.J., Lake, B.G., and Evans, J.G. (1987). Peroxisome induction studies on seven phthalate esters. Toxicol. Ind. Health 3:7-24.
10. Bartosiewicz, M., Penn, S., and Buckpitt, A. (2001). Applications of gene arrays in environmental toxicology: fingerprints of gene regulation associated with cadmium chloride, benzo(a)pyrene, and trichloroethylene. Environ. Health Perspect. 109:71-74.
11. Bentley, P., Calder, I., Elcombe, D., Grasso, P., Stringer, D., and Wiegand, H.J. (1993). Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem. Toxicol. 31:857-907.
12. Blumcke, S., Schwartzkopff, W., Lobeck, H., Edmondson, N.A., Prentice, D.E., and Blane, G.F. (1983). Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients. Atherosclerosis. 46:105-116.
13. Bruckner, J.V., Davis, B.D., and Blancato, J.N. (1989). Metabolism, toxicity, and carcinogenicity of trichloroethylene. Crit. Rev. Toxicol. 20:31-50.
14. Bruning, T., Pesch, B., Wiesenhutter, B., Rabstein, S., Lammert, M., Baumuller, A., and Bolt, H.M. (2003). Renal cell cancer risk and occupational exposure to trichloroethylene: Results of a consecutive case-control study in Arnsberg, Germany. Am. J. Ind. Med. 43:274-285.
15. Buben, J.A., and O'Flaherty, E.J. (1985). Delineation of the role of metabolism in the hepatotoxicity of trichloroethylene and perchloroethylene: A dose-effect study. Toxicol Appl Pharmacol. 78:105-122.
16. Bull, R.J., Sanchez, I.M., Nelson, M.A., Larson, J.L., and Lansing, A.J. (1990). Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology 63:341-359.
17. Bull, R.J. (2000). Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate. Environ. Health Perspect. 108 (Suppl. 2):241-259.
18. Bull, R.J., Orner, G.A., Cheng, R.S., Stillwell, L., Stauber, A.J., Sasser, L.B., Lingohr, M.K., and Thrall, B.D. (2002). Contribution of dichloroacetate and trichloroacetate to liver tumor induction in mice by trichloroethylene. Toxicol. Appl. Pharmacol. 182:55-65.
19. Caldwell, J.C., and Keshava, N. (2006). Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis. Environ. Health Perspect. 114:1457-1463.
20. Caldwell, J.C., Keshava, N., and Evans, M.V. (2007). Difficulty of mode of action determination for trichloroethylene: An example of complex interactions of metabolites and other chemical exposures. Environ. Mol. Mutagen. 49:142-154.
21. Carmichael, N.G., Enzmann, H., Pate, I., and Waechter, F. (1997). The significance of mouse liver tumor formation for carcinogenic risk assessment: Results and conclusions from a survey of ten years of testing by the agrochemical industry. Environ. Health Perspect. 105:1196-1203.
22. Carter, J.H., Carter, H.W., and DeAngelo, A.B. (1995). Biochemical, pathologic and morphometric alterations induced in male B6C3F1mouse liver by short-term exposure to dichloroacetic acid. Toxicol. Lett. 81:55-71.
23. Cattley, R.C., and Popp, J.A. (1989). Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver. Cancer Res. 49:3246-3251.
24. Cattley, R.C., Conway, J.G., and Popp, J.A. (1987). Association of persistent peroxisome proliferation and oxidative injury with hepatocarcinogenicity in female F-344 rats fed di(2-ethylhexyl)phthalate for 2 years. Cancer Lett. 38:15-22.
25. Channel, S.R., Latendresse, J.R., Kidney, J.K., Grabau, J.H., Lane, J.W., Steel-Goodwin, L., and Gothaus, M.C. (1998). A subchronic exposure to trichloroethylene causes lipid peroxidation and hepatocellular proliferation in male B6C3F1 mouse liver. Toxicol. Sci. 43:145-154.
26. Cheung, C., Akiyama, T.E., Ward, J.M., Nicol, C.J., Feigenbaum, L., Vinson, C., and Gonzalez, F.J. (2004). Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha. Cancer Res. 64:3849-3854.
27. Chiu, W.A., Okino, M.S., Lipscomb, J.C., and Evans, M.V. (2006). Issues in the pharmacokinetics of trichloroethylene and its metabolites. Environ. Health Perspect. 114:1450-1456.
28. Clewell, H.J. 3rd, Gentry, P.R., Covington, T.R., and Gearhart, J.M. (2000). Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ. Health Perspect. 108:S283-S305.
29. Corton, J.C., Anderson, S.P., and Stauber, A. (2000). Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu. Rev. Pharmacol. Toxicol. 40:491-518.
30. Corton, J.C., Fan, L.Q., Brown, S. Anderson, S.P., Bocos, D., Cattley, R.C., Mode, A. and Gustafsson, J.A. (1998). Down-regulation of cytochrome P4502C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals. Mol. Pharmacol. 54:463-473.
31. Corton, J.C., Lapinskas, P.J., and Gonzalez, F.J. (1999). Central role of PPARalpha in the mechanism of action of hepatocarcinogenic peroxisome proliferators. Mutat. Res. 448:139-151.
32. Crebelli, R., and Carere, A. (1989). Genetic toxicology of 1,1,2-trichloroethylene. Mutat. Res. 221:11-37.
33. Daniel, F.B., DeAngelo, A.B., Stober, J.A., Olson, G.R., and Page, N.P. (1992a). Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde, and dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol. 19:159-168.
34. Daniel, F.B., Robinson, M., Stober, J.A., Page, N.P., and Olson, G.R. (1992b). Ninety-day toxicity study of chloral hydrate in the Sprague-Dawley rat. Drug Chem Toxicol. 15:217-332.
35. David, R.M., Moore, M.R., Cifone, M.A. Finney, D.C., and Guest, D. (1999). Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery. Toxicol. Sci. 50:195-205.
36. Davidson, I.W., and Beliles, R.P. (1991). Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics. Drug Metab. Rev. 23:493-599.
37. De La Iglesia, F.A., Lewis, J.E., Buchanan, R.A., Marcus, E.L., and McMahon, G. (1982) Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment. Atherosclerosis 43:19-37.
38. DeAngelo, A.B., Daniel, F.B., McMillan, L., Wernsing, P., and Savage, R.E., Jr. (1989). Species and strain sensitivity to the induction of peroxisome proliferation by chloroacetic acids. Toxicol Appl Pharmacol. 101:285-298.
39. DeAngelo, A.B., Daniel, F.B., Most, B.M., and Olson, G.R. (1996). The carcinogenicity of dichloroacetic acid in the male fischer 344 rat. Toxicology 114:207-221.
40. DeAngelo, A.B., Daniel, F.B., Most, B.M., and Olson, G.R. (1997). Failure of monochloroacetic acid and trichloroacetic acid administered in the drinking water to produce liver cancer in male F344/N rats. J. Toxicol. Environ. Health 52:425-445.
41. DeAngelo, A.B., Daniel, F.B., Stober, J.A., and Olson, G.R. (1991). The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol. 16:337-347.
42. DeAngelo, A.B., George, M.H., and House, D.E. (1999). Hepatocarcinogenicity in the male B6C3F1 mouse following a lifetime exposure to dichloroacetic acid in the drinking water: Dose-response determination and modes of action. J. Toxicol. Environ. Health A 48:485-507.
43. Dees, C., and Travis, C. (1993). The mitogenic potential of trichloroethylene in B6C3F1 mice. Toxicol. Lett. 69:129-137.
44. Dees, C., and Travis, C. (1994). Trichloroacetate stimulation of liver DNA synthesis in male and female mice. Toxic. Lett. 70:343-355.
45. Dirvin, H.A., van den Brock, P.H., and Jongeneelen, F.J. (1990). Effect of di(2-ethylhexyl)phthalate on enzyme activity levels in liver and serum of rats. Toxicology 65:199-207.
46. Elcombe, C.R. (1985). Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: A biochemical human hazard assessment. Arch. Toxicol. Suppl. 8:6-17.
47. Elcombe, C.R., Rose, M.S., and Pratt, I.S. (1985). Biochemical, histological, and ultrastructural changes in rat and mouse liver following the administration of trichloroethylene: Possible relevance to species differences in hepatocarcinogenicity. Toxicol. Appl. Pharmacol. 79:365-376.
48. Ganning, A.E., Olsson, M.J., Brunk, U., and Dallner, G. (1990). Effects of prolonged treatment with phthalate ester on rat liver. Pharmacol. Toxicol. 67:392-401.
49. Gariot, P., Barrat, E., Mejean, L., Pointel, J.P., Drouin, P., and Debry, G. (1983). Fenofibrate and human liver. Lack of proliferation of peroxisomes. Arch. Toxicol. 53:151-163.
50. George, M.H., Moore, T., Kilburn, S. Olson, G.R., and DeAngelo, A.B. (2000). Carcinogenicity of chloral hydrate administered in drinking water to the male F344//N rat and male B6C3F mouse. Toxicol. Pathol. 28: 610-618.
51. Gervois, P., Torra, I.P., Chinetti, G., Grotzinger, T., Dubois, G., Fruchart, J.C., Fruchart-Najib, J., Leitersdorf, E., and Staels, B. (1999). A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity. Mol. Endocrinol. 13:1535-1549.
52. Goldsworthy, T.L., and Popp, J.A. (1987). Chlorinated hydrocarbon-induced peroxisomal enzyme activity in relation to species and organ carcinogenicity. Toxicol. Appl. Pharmacol. 88:225-233.
53. Grasl-Kraupp, B., Waldhor, T., Huber, W., and Schulte-Hermann, R. (1993). Glutathione S-transferase isoenzyme patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital. Carcinogenesis 14:2407-2412.
54. Hanefeld, J., Kemmer, C., and Kadner, E. (1983). Relationship between morphological changes and lipid-lowering action of pchlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man. Atherosclerosis 46:239-246.
55. Hanefeld, M., Kemmer, C., Leonhardt, W., Kunze, K.D., Jaross, W., and Haller, H. (1980). Effects of p-chlorophenoxyisobutyric acid (CPIB) on the human liver. Atherosclerosis 36:159-172.
56. Hanselman, J.C., Vartanian, M.A., Koester, B.P., Gray, S.A., Essenburg, A.D., Rea, T.J., Bisgaier, C.L., and Pape, M.E. (2001). Expression of the mRNA encoding truncated PPAR alpha does not correlate with hepatic insensitivity to peroxisome proliferators. Mol. Cell Biochem. 217:91-97.
57. Hansen, J., Raaschou-Nielsen, O., Christensen, J.M., Johansen, I., McLaughlin, J.D., Lipworth, L., Blot, W.J., and Olsen, J.H. (2001). Cancer incidence among Danish workers exposed to trichloroethylene. J. Occup. Environ. Med. 43:133-139.
58. Hays, T., Rusyn, I., Burns, A.M., Kennett, M.J., Ward, J.M., Gonzalez, F.J., and Peters, J.M. (2005). Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis. Carcinogenesis 26:219-227.
59. st codon activation in archival proliferative hepatic lesions isolated from female B6C3F1 mice exposed to the leukotriene D4-antagonist, LY171883. Carcinogenesis 15:331-333.
60. Herren-Freund, S.L., Pereira, M.A., Khoury, M.D., and Olson, G. (1987). The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver. Toxicol. Appl. Pharmacol. 90:183-189.
61. Howroyd, P., Swanson, C., Dunn, C., Cattley, R.C., and Corton, J.C. (2004). Decreased longevity and enhancement of age-dependent lesions in mice lacking the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha). Toxicol. Pathol. 32:591-599.
62. Huff, J., Melnick, R., Tomatis, L., LaDou, J., and Teitelbaum, D. (2002). Trichloroethylene and cancers in humans. Toxicology 197:185-187.
63. IARC. (1996). WHO International Agency for Research on Cancer. Some pharmaceutical drugs. IARC Monogr. Eval. Carcinogen. Risk Chem. Hum. 66:391-426.
64. Isenberg, J.S. Kamendulis, L.M., Smith, J.H., Ackley, D.C., Pugh, G., Jr., Lington, A.W., and Klaunig, J.E. (2000). Effects of di-2-ethylhexyl phthalate (DEHP) on gap-junctional intercellular communication (GJIC), DNA synthesis, and peroxisomal beta oxidation (PBOX) in rat, mouse, and hamster liver. Toxicol. Sci. 56:73-85.
65. Issemann, I., and Green, S. (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347:645-650.
66. Ito, Y., Yamanoshita, O., Asaeda, N., Tagawa, Y., Lee, C.H., Aoyama, T., Ichihara, G., Furuhashi, K., Kamijima, M., Gonzalez, F.J., and Nakajima, T. (2007). Di(2-ethylhexyl)phthalate induces hepatic tumorigenesis through a peroxisome proliferator-activated receptor alpha-independent pathway. J. Occup. Health 49:172-182.
67. Kato-Weinstein, J., Stauber, A.J., Orner, G.A., Thrall, B.D., and Bull R. (2001). Differential effects of dihalogenated and trihalogenated acetates in the liver of B6C3F1 mice. J. Appl. Toxicol. 21:91-89.
68. Keshava, N., and Caldwell, J.C. (2006). Key issues in the role of peroxisome proliferator-activated receptor agonism and cell signaling in trichloroethylene toxicity. Environ. Health Perspect. 114:1464-1470.
69. Kim, D., and Ghanayem, B.I. (2006). Comparative metabolism and disposition of trichloroethylene in Cyp2e1-/-and wild-type mice. Drug Metab. Dispos. 34:2020-2027.
70. Klaunig, J.E., Babich, M.A., Baetcke, K.P., Cook, J.C., Corton, J.C., David, R.M., DeLuca, J.G., Lai, D.Y., McKee, R.H., Peters, J.M., Roberts, R.A., and Fenner-Crisp, P.A. (2003). PPARα agonist-induced rodent tumors: Modes of action and human relevance. Crit. Rev. Toxicol. 33:655-780.
71. Komulainen., H. (2004). Experimental cancer studies of chlorinated by-products. Toxicology 198:239-248.
72. Larson, J.L., and Bull, R.J. (1992). Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice. Toxicol. Appl. Pharmacol. 115:268-277.
73. Lash, L.H., and Parker, J.C. (2001). Hepatic and renal toxicities associated with perchloroethylene. Pharmacol. Rev. 53:177-208.
74. Lash, L.H., Parker, J.C., and Scott, C.S. (2000). Modes of action of trichloroethylene for kidney tumorigenesis. Environ. Health Perspect. 108 (Suppl. 2):225-240.
75. Latendresse, J.R., and Pereira, M.A. (1997). Dissimilar characteristics of N-methyl-N-nitrosourea-initiated foci and tumors promoted by dichloroacetic acid or trichloroacetic acid in the liver of female B6C3F1 mice. Toxicol. Pathol. 25:433-440.
76. Laughter, A.R., Dunn, C.S., Swanson, C.L., Howroyd, P., Cattley, R.C., and Corton, J.C. (2004). Role of the peroxisome proliferator-activated receptor alpha (PPARalpha) in responses to trichloroethylene and metabolites, trichloroacetate and dichloroacetate in mouse liver. Toxicology 203:83-98.
77. Lawrence, J.W., Li, Y., Chen, S., DeLuca, J.G., Berger, J.P., Umbenhauer, D.R., Moller, D.E., and Zhou, G. (2001). Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expresson. J. Biol. Chem. 276:31521-31527.
78. Leakey, E.A., Seng, J.E., Latendresse, J.R., Hussain, N., Allen, L.J., and Allaaben, W.T. (2003). Dietary controlled carcinogenicity study of chloral hydrate in male B6C3F mice. Tox and Appl Pharmacol. 193:266-280.
79. Lee, S.S., Pineau, T., Drago, J., Lee, E.J., Owens, J.W., Kroetz, D.L., Fernandez-Salguero, P.M., Westphal, H., and Gonzalez, F.J. (1995). Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15:3012-3022.
80. Lock, E.A., and Reed, C.J. (2006). Trichloroethylene: Mechanisms of renal toxicity and renal cancer and relevance to risk assessment. Toxicol. Sci. 91:313-331.
81. Lock, E.A., Mitchell, A.M., and Elcombe, C.R. (1989). Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu. Rev. Pharmacol. Toxicol. 29:145-163.
82. Luebker, D.J., Hansen, K.J., Bass, N.M., Butenhoff, J.L, and Seacat, A.M. (2002). Interactions of fluorochemicals with rat liver fatty acid-binding protein. Toxicology 176:175-185.
83. Mahle, D.A., Godfrey, R.J., Buttler, G.W., Narayanan, L.A., Taylor, A., and Fisher, J.W., (2001). Pharmacokinetics and metabolism of dichloroacetic and trichloroacetic acid administered in drinking water in rats and mice. USAF Technical Report. (AFRL-HE-WP-TR-2001-0059), AFRL/HE, Operational Toxicology Branch, WPAFB, OH 34433.
84. Maloney, E.K., andWaxman, D.J. (1999). Trans-activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals. Toxicol. Appl. Pharmacol. 161:209-218.
85. Mather, G.G., Exon, J.H., and Koller, L.D. (1990). Subchronic 90 day toxicity of dichloroacetic and trichloroacetic acid in rats. Toxicology 64:71-80.
86. Mehendale, H.M. (2000). PPAR-alpha: A key to the mechanism of hepatoprotection by clofibrate. Toxicol. Sci. 57:187-190.
87. Melnick, R.L., Jameson, C.W., Goehl, T.J., Maronpot, R.R., Collins, B.J., Greenwell, A., Harrington, F.W., Wilson, R.E., Tomaszewski, K.E., and Agarwal, D.K. (1987). Toxicity of microencapsulated trichloroethylene in Fisher 344 rats. Fundam. Appl. Toxicol. 8:432-442.
88. Merdink, J.L., Bull, R.J., and Schultz, I.R. (2000). Trapping and identification of the dichloroacetate radical from the reductive dehalogenation of trichloroacetate by mouse and rat liver microsomes. Free Radical Biol .Med. 29:125-130.
89. Merdink, J.L., Gonzalez-Leon, A., Bull, R.J., and Schultz, I.R. (1998). The extent of dichloroacetate formation from trichloroethylene, chloral hydrate, trichloroacetate, and trichloroethanol in B6C3F1 mice. Toxicol. Sci. 45:33-41.
90. Miller, J.H., Minard, K., Wind, R.A., Orner, G.A., Sasser, L.B., and Bull, R.J. (2000). In vivo MRI measurements of tumor growth induced by dichloroacetate: Implications for mode of action. Toxicology 145:115-125.
91. Miller, R.E., and Guengerich, F.P. (1982). Oxidation of trichloroethylene by liver microsomal cytochrome P-450: Evidence for chlorine migration in a transition state not involving trichloroethylene oxide. Biochemistry 21:1090-1097.
92. Mitchell, F.E., Price, S.C., Hinton, R.H., Grasso, P., and Bridges, J.W. (1985). Time and dose-response study of the effects on rats of the plasticizer di(2-ethylhexyl) phthalate. Toxicol. Appl. Pharmacol. 81:371-392.
93. Moore, M.M., and Harrington-Brock, K. (2000). Mutagenicity of trichloroethylene and its metabolites: implications for the risk assessment of trichloroethylene. Environ. Health Perspect. 108 (Suppl. 2):215-223.
94. Morimura, K., Cheung, C., Ward, J.M., Reddy, J.K., and Gonzalez, J.F. (2006). Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis. Carcinogenesis 27:1074-1080.
95. Nakajima, T., Kamijo, Y., Usuda, N., Liang, Y., Fukushima, Y., Kametani, K., Gonzalez, F.J., and Aoyama, T. (2000). Sexdependent regulation of hepatic peroxisome proliferation in mice by trichloroethylene via peroxisome proliferator-activated receptor alpha (PPARalpha). Carcinogenesis 21:677-682.
96. National Cancer Institute. (1977). Bioassay of the tetrachloroethylene for possible carcinogenicity. DHEW publ. no. 77-813. Washington, DC: NCI.
97. National Cancer Institute. (1976). Carcinogenesis bioassay of trichloroethylene. NCI-CG-TR-1 DHEW/Pub/NIH-76-802. Washington, DC: NCI.
98. National Toxicology Program. (1983). NTP carcinogenesis studies of trichloroethylene (without epidhlorohydrin) (CAS No. 79-01-6) in F344/N Rats and B6C3F1 mice (Gavage Studies). Natl. Toxicol. Program Tech. Rep. Ser. 243:1-174.
99. National Toxicology Program. (1982). Carcinogenesis bioassay of di(2-ethylhexyl)phthalate (CAS No. 117-81-7) in F344 rats and B6C3F1 mice (feed studies). Natl. Toxicol. Program Tech. Rep. Ser 217:1-127.
100. National Toxicology Program. (1986). NTP toxicology and carcinogenesis studies of tetrachloroethylene (perchloroethylene) CAS No. 127-18-4) in F344/N rats and B6C3F1 mice (inhalation studies). Natl. Toxicol. Program Tech. Res. Ser. 311:1-197.
101. National Toxicology Program. (1988). NTP toxicology and carcinogenesis studies of trichloroethylene (CAS No. 79-01-6) in four strains of rats (ACI, August, Marshall, Osborne-Mendel) (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 273:1-299.
102. National Toxicology Program. (2002). NTP Technical report on the toxicology and carcinogenesis studies of chloral hydrate (CAS No. 302-17-0) in B6C3F1 mice (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 502:1-197.
103. Nelson, M.A., Lansing, A.J., Sanchez, I.M., Bull, R.J., and Springer, D.L. (1989). Dichloroacetic acid and trichloroacetic acid-induced DNAstrand breaks are independent of peroxisome proliferation. Toxicology 58:239-248.
104. Ochs, J.B., Baldwin, L.A., Leonard, D.A., and Calabrese, E.J. (1992). Effects of joint exposures to selected peroxisome proliferators on hepatic acyl-CoA oxidase activity in male B6C3F1 mice. Hum. Exp. Toxicol. 11:83-88.
105. Odum, J. Green, T., Foster, J.R., and Hext, P.M. (1988). The role of trichloroacetic acid and peroxisome proliferation in the differences in carcinogenicity of perchloroethylene in the mouse and rat. Toxicol. Appl. Pharmacol. 92:103-112.
106. Okamoto, T., and Shiwaku, K. (1994). Fatty acid composition in liver, serum and brain of rat inhalated with trichloroethylene. Exp. Toxicol. Pathol. 46:133-141.
107. Palmer, C.N., Hsu, M.H., Griffin, K.J., Raucy, J.L., and Johnson, E.F. (1998). Peroxisome proliferator activated receptor-alpha expression in human liver. Mol. Pharmacol. 53:14-22.
108. Parrish, J.M., Austin, Stevens E.W., Kinder, D.H., and Bull R.J. (1996). Haloacetate-induced oxidative damage to DNA in the liver of male B6C3F1 mice. Toxicology 110:103-111.
109. Pereira, M.A., and Phelps, J.B. (1996). Promotion by dichloroacetic acid and trichloroacetic acid of N-methyl-N-nitrosourea-initiated cancer in the liver of female B6C3F1 mice. Cancer Lett. 102:133-141.
110. Pereira, M.A., Li, K., and Kramer, P.M. (1997). Promotion by mixtures of dichloroacetic acid and trichloroacetic acid of N-methyl-N-nitrosourea-initiated cancer in the liver of female B6C3F1 mice. Cancer Lett. 115:15-23.
111. Pereira, M.A., Wang, W., Kramer, P.M., and Tao, L. (2004). Prevention by methionine of dichloroacetic acid-induced liver cancer and DNA hypomethylation in mice. Toxicol. Sci. 77:243-248.
112. Pesch, B., Haerting, J., Ranft, U., Klimpel, A., Oelschlagel, B., and Schill, W. (2000). Occupational risk factors for renal cell carcinoma: Agent-specific results from a case-control study in Germany, MURC Study Group. Multicenter urothelial and renal cancer study. Int. J. Epidemiol. 29:1014-1024.
113. Peters, J.M., Aoyama, T., Cattley, R.C., Nobumitsu, U., Hashimoto, T., and Gonzalez, F.J. (1998). Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver. Carcinogenesis 19:1989-1994.
114. Peters, J.M., Cattley, R.C., and Gonzalez, F.J. (1997). Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis 18:2029-2033.
115. Peters, J.M., Cheung, C., and Gonzalez, F.J., (2005). Peroxisome proliferator-activated-alpha and liver cancer: Where do we stand? J. Mol. Med. 83:774-785.
116. Peters, J.M., Rusyn, I., Rose, M.L., Gonzalez, F.J., and Thurman, R.G. (2000). Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: Implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis. Carcinogenesis 21:823-826.
117. Phoon, W.H., Chan, M.O., Rajan, V.S., Tan, K.J., Thirumoorthy, T., and Goh, C.L. (1984). Stevens-Johnson syndrome associated with occupational exposure to trichloroethylene. Contact Dermatitis 10:270-276.
118. Poon, R., Nadeau, B., and Chu, I. (2000). Biochemical effects of chloral hydrate on male rats following 7-day drinking water exposure. J. Appl. Toxicol. 20:455-461.
119. Prout, M.S., Provan, W.M., and Green, T. (1985). Species differences in response to trichloroethylene. I. Pharmacokinetics in rats and mice. Toxicol. Appl. Pharcacol. 79:389-400.
120. Raaschou-Nielsen, O., Hansen, J., McLaughlin, J.K., Kolstad, H., Christensen, J.M., Tarone, R.E., and Olsen J.H. (2003). Cancer risk among workers at Danish companies using trichloroethylene: A cohort study. Am. J. Epidemiol. 158:1182-1192.
121. Rao, M.S., and Reddy, J.K. (1996). Hepatocarcinogenesis of peroxisome proliferators. Ann N Y Acad Sci. 804:573-587.
122. Reddy, J.K., Reddy, M.K., Usman, M.I., Lalwani, N.D., and Rao, M.S. (1986). Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug. Environ. Health Perspect. 65:317-327.
123. Richmond, R.E., DeAngelo, A.B., Potter, C.L., and Daniel, F.B. (1991). The role of hyperplastic nodules in dichloroacetic acid-induced hepatocarcinogenenesis in B6C3F1 male mice. Carcinogenesis 12:1383-1387.
124. Rijhsinghani, K.S., Abrahams, C., Swerdlow, M.A., Rao, K.V., and Ghose, T. (1986). Induction of neoplastic lesions in the livers of C57BL x C3HF1 mice by chloral hydrate. Cancer Detect. Prev. 9:279-288.
125. Roberts, R.A., James, N.H., Hasmall, S.C., Holden, P.R., Lambe, K., Macdonald, N., West, D., Woodyatt, N.J., and Whitcome, D. (2000). Apoptosis and proliferation in nongenotoxic carcinogenesis: Species differences and role of PPARalpha. Toxicol. Lett. 112-113:49-57.
126. Roglans, N., Bellido, A., Rodriguez, C., Cabrero, A., Novell, F., Ros, E., Zembon, D., and Laguna, J.C. (2002). Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver. Clin. Pharcol. Ther. 72:692-701.
127. Sanchez, I.M., and Bull, R.J. (1990). Early induction of reparative hyperplasia in the liver of B6C3F1 mice treated with dichloroacetate and trichloroacetate. Toxicology 64:33-46.
128. Schumann, A.M., Quast, J.F., and Watanabe, P.G. (1980). The pharmacokinetics and macromolecular interactions of perchloroethylene in mice and rats as related to oncogenicity. Toxicol. Appl Pharcol. 55:207-219.
129. Seng, J.E., Agrawal, N., Horsley, E.T.M., Leakey, T.I., Scherer, E.M., Xia, S., Allaben, W.T., and Leakey J.E.A. (2003). Toxicokinetics of chloral hydrate in ad libitum-fed, dietary-controlled, and calorically restricted male B6C3F mice following short-term exposure. Toxicol. Appl. Pharmacol. 193:281-292.
130. Short, R.D., Robinson, E.C., Lington, A.W., and Chin, A.E. (1987). Metabolic and peroxisome proliferation studies with di(2-ethylhexyl)phthalate in rats and monkeys. Toxicol. Ind. Health 3:185-195.
131. Snyder, R.D., Pullman, J., Carter, J.H., Carter, H.W., and DeAngelo, A.B. (1995). In vivo administration of dichloroacetic acid suppresses spontaneous apoptosis in murine hepatocytes. Cancer Res. 55:3702-3705.
132. Stauber, A.J., Bull, R.J., and Thrall, B.D. (1998). Dichloroacetate and trichloroacetate promote clonal expansion of anchorage-independent hepatocytes in vivo and in vitro. Toxicol. Appl. Pharmacol. 150:287-294.
133. Stauber, A.J.,and Bull, R.J. (1997). Differences in phenotype and cell replicative behavior of hepatic tumors induced by dichloroacetate (DCA) and trichloroacetate (TCA). Toxicol. Appl. Pharmacol. 144:235-246.
134. Stevens, D.K., Eyre, R.J., and Bull, R.J. (1992). Adduction of hemoglobin and albumin in vivo by metabolites of trichloroethylene, trichloroacetate, and dichloroacetate in rats and mice. Fundam. Appl. Toxicol. 19:336-342.
135. Stott, W.T., Quast, J.F., and Watanabe, P.G. (1982). The pharmacokinetics and macromolecular interactions of trichloroethylene in mice and rats. Toxicol. Appl. Pharmacol. 62:137-151.
136. Styles, J.A., Wyatt, I., and Coutts C. (1991). Trichloroacetic acid: Studies on uptake and effects on hepatic DNA and liver growth in mouse. Carcinogenesis 12:1715-1719.
137. Tachibana, K., Kobayshi, Y., Tanaka, T., Tagami, M., Sugiyama, A., Katayama, T., Ueda, C., Yamasaki, D., Ishimaoto, K., Sumitomo, M., Uchiyama, Y., Kobro, T., Sakai, J., Hamakubo, T., Kodama, T., and Doi, T. (2005). Gene expression profiling of potential peroxisome proliferator-activated receptor (PPAR) target genes in human hepatoblastoma cell lines inducibly expressing different PPAR isoforms. Nucl. Recpt. 3:3.
138. Tao, L., Ge, R., Xie, M., Kramer, P.M., and Pereira, M.A. (1999). Effect of trichloroethylene on DNA methylation and expression of early-intermediate protooncogenes in the liver of B6C3F1 mice. J. Biochem. Mol. Toxicol. 13:231-237.
139. Tao, L., Yang, S., Xie, M., Kramer, P.M., and Pereira, M.A. (2000a). Hypomethylation and overexpression of c-jun and c-myc protooncogenes and increased DNA methyltransferase activity in dichloroacetic and trichloroacetic acid-promoted mouse liver tumors. Cancer Letters. 158:185-193.
140. Tao, L., Yang, S., Xie, M., Kramer, P.M., and Pereira, M.A. (2000b). Effects of Trichloroethylene and its metabolites, dichloroacetic acid and trichloroacetic acid, on the methylation and expression of c-Jun and c-Myc protooncogenes in mouse liver: Prevention by methionine. Toxicol. Sci. 54:399-407.
141. Tugwood, J.D., Aldridge, T.C., Lambe, K.G., Macdonald, N., and Woodyatt, J.G. (1996). Peroxisome proliferator-activated receptors: Structures and function. Ann. NY Acad. Sci. 804:252-265.
142. Valles, E.G., Laughter, A.R., Dunn, C.S., Cannelle, S., Swanson, C.L., Cattley, R.C., and Corton, J.C. (2003). Role of the peroxisome proliferator-activated receptor alpha in responses to diisononyl phthalate. Toxicology 191:211-225.
143. Walgren, J.E., Kurtz, D.T.,and McMillan, J.M. (2000a). Expression of PPAR(alpha) in human hepatocytes and activation by trichloroacetate and dichloroacetate. Res. Commun. Mol. Pathol. Pharmacol. 108:116-132.
144. Walgren, J.E., Kurtz, D.T., and McMillan, J.M. (2000b). The effect of the trichloroethylene metabolites trichloroacetate and dichloroacetate on peroxisome proliferation and DNA synthesis in cultured human hepatocytes. Cell. Biol. Toxicol. 16:257-273.
145. Walgren, J.L., Jollow, D.J., and McMillan, J.M. (2004). Induction of peroxisome proliferation in cultured hepatocytes by a series of halogenated acetates. Toxicology 197:189-197.
146. Wartenberg, D., Reyner, D., and Scott, C.S. (2000). Trichloroethylene and cancer: Epidemiologic evidence. Environ. Health Perspect. 108 (Suppl. 2):161-176.
147. Wu, C., and Schaum, J. (2000). Exposure assessment of trichloroethylene. Environ. Health Perspect. 108 (Suppl. 2):359-363.
148. Yokoyama, Y., Tsuchida, S., Hatayama, I., and Sato, K. (1993). Lack of peroxisomal enzyme inducibility in rat hepatic preneoplastic lesions induced by
149. Zhou, Y.C., and Waxman, D.J. (1998). Activation of peroxisome proliferator-activated receptors by chlorinated hydrocarbons and endogenous steroids. Environ. Health Perspect. 106(Suppl. 4):983-988.